PMA

P880027: MICROSOFTRAC TM (PTCA) CATHETER

FDA PMA · Catheters, transluminal coronary angioplasty, percutaneous · Boston Scientific

Key facts

PMA number P880027
Trade name MICROSOFTRAC TM (PTCA) CATHETER
Generic name Catheters, transluminal coronary angioplasty, percutaneous
Applicant Boston Scientific
Owner/operator Boston Scientific Corporation
Product code LOX
Approval date Apr 14, 1989
Docket number 89M-0143
Notice date May 19, 1989
Establishment registration 2134265
FEI number 3002095335

At a glance

  • 10–99 Supplements
  • Oct 31, 2005 Latest supplement decision
  • Yes Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals